Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricBMYBristol Myers SquibbGSKGSK plcPFEPfizer
Snapshot
Price$62.79$50.82$27.91
Market cap$118.71B$102.51B$138.61B
Valuation
P/E21.5x13.8x21.2x
Forward P/E17x9.8x22.3x
Growth
Revenue growth1.8%4.0%1.4%
EPS growth26.3%86.7%-5.3%
Profitability
Net margin12.3%17.8%11.8%
ROE41.6%35.8%8.4%
Balance sheet & cash
Debt / equity2.44x1.08x0.75x
Free cash flow yield15.4%3.8%11.2%
Dividend yield4.5%3.5%6.6%
Verdict
Investment ratingFavorable· 60Favorable· 66Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBMYtoday $63GSKtoday $51PFEtoday $28
2027$59.46 – $87.21+39% CAGR$71.17 – $104.39+105% CAGR$21.35 – $31.32+12% CAGR
2028$75.08 – $110.12+32% CAGR$132.90 – $194.92+96% CAGR$21.78 – $31.94+7% CAGR
2029$94.81 – $139.05+30% CAGR$248.16 – $363.97+93% CAGR$22.21 – $32.58+5% CAGR
2030$119.72 – $175.58+29% CAGR$463.40 – $679.65+91% CAGR$22.66 – $33.23+4% CAGR
2031$151.17 – $221.71+29% CAGR$865.30 – $1,269.11+90% CAGR$23.11 – $33.90+4% CAGR
5-yr CAGR19.2% – 28.7%76.3% – 90.3%-3.7% – 4.0%